FDA Inspection 1028830 — Beijing Rimeng Biological Technology Co. Ltd.
The FDA completed an inspection of Beijing Rimeng Biological Technology Co. Ltd. on October 11, 2017 in Beijing. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- October 11, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Beijing (China)